Daewoong Pharmaceutical announced that they release a complex Incrementally Modified Drug 'Olostar'
Daewoong Pharmaceutical announced that they release a complex Incrementally Modified Drug 'Olostar'. 'Olostar' is the world's first complex IMD which is composed of the family of ARB (Olmesartan) and the family of statin (Rosuvastatin), and it can manage hypertension and dyslipidemia at the same ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
